前列腺癌PSMA PET显像操作中国专家共识  

Chinese expert consensus on the operation of PSMA PET imaging for prostate cancer

作　　者：中华医学会核医学分会 刘建军[2] 周翔[2] 李千瑞 汪静 Chinese Society of Nuclear Medicine;Liu Jianjun;Wang Jing(不详;Department of Nuclear Medicine,Renji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200127,China;Department of Nuclear Medicine,the First Afiliated Hospital of the Air Force Medical University,Xi'an 710032,China)

机构地区：[1]不详 [2]上海交通大学医学院附属仁济医院核医学科,上海200127 [3]四川大学华西医院核医学科 [4]空军军医大学第一附属医院核医学科,西安710032

出　　处：《中华核医学与分子影像杂志》2025年第1期35-40,共6页Chinese Journal of Nuclear Medicine and Molecular Imaging

基　　金：国家自然科学基金(92259103)。

摘　　要：前列腺特异膜抗原(PSMA)PET在前列腺癌的诊断、分期及复发灶探查中已得到广泛应用,是前列腺癌全周期管理中的重要影像学手段。国内近年来发展迅速,但在操作应用领域仍呈现出参差不齐的状况。该共识基于文献证据和国内多学科专家共同讨论获得,旨在为前列腺癌PSMA PET显像提供规范化应用程序,以指导其在临床实践与研究中的应用,推动PSMA PET在前列腺癌患者全周期管理中的应用和发展。共识主要内容包括临床适应证、检查操作程序、图像解读和报告等。Prostate specific membrane antigen(PSMA)PET has been widely applied in diagnosing,staging,and detecting recurrent prostate cancer lesions,becoming an important imaging modality in the full-cycle management of prostate cancer.Despite rapid developments in this field in China in recent years,there still needs to be more standardization in its operational application.This article aims to provide a standardized application protocol for PSMA PET imaging in prostate cancer by collecting evidence from the literature and reaching a consensus through discussions among multidisciplinary experts in China.The goal of this consensus is to guide its application in clinical practice and research and to promote the application and development of PSMA PET in the full-cycle management of prostate cancer patients.The main consensus content includes clinical indications,examination procedures,image interpretation,and reporting.

关 键 词：多数赞同 前列腺肿瘤 前列腺特异膜抗原 正电子发射断层显像术 

分 类 号：R737.25[医药卫生—肿瘤] R817[医药卫生—临床医学]